Fainting is not solely caused by external factors. Your genes also play a part. In a study looking at data from more than 400,000 individuals, scientists have identified the first gene that predisposes to fainting.

Scientists have examined more than 25 years of data to reveal new insights into predicting the age of onset for Huntington disease.

Researchers report that indole-3-carbinol (I3C) – a natural compound found in broccoli – can be used to therapeutically target a gene (WWP1) known to play a role in several human cancers.

Researchers at UC Davis and UC San Francisco have found a way to teach a computer to precisely detect one of the hallmarks of Alzheimer's disease in human brain tissue, delivering a proof of concept for a machine-learning approach to distinguishing critical markers of the disease.

A new study suggests that the next generation of hearing aids might match a listener's brainwaves with the "soundprint" of a speaker's voice, using that information to automatically turn up the volume on that speaker.

In just a few short weeks, tens of thousands of newly minted doctors will start the most intense year of their training: the first year of residency, also called the intern year. A new study suggests that between now and next summer, that experience will make their DNA age six times faster than normal.

The Lipidomics Excellence Award (LEA) was founded to strengthen life sciences through lipidomics. After reviewing the many high-quality submitted projects, the LEA jury has announced the three awardees.

Dr Evangelia Petsalaki is a Group Leader at the European Bioinformatics Group, where her research team study human cell signaling in health and disease conditions. Collaborating with teams specializing in MS, imaging and cell biology, their aim is to make both predictive and conditional models so they can anticipate what might happen in a biological network under different conditions.

At the British Neuroscience Association's Festival of Neuroscience 2019, we pulled aside one of the BNA's credibility board, Dr Verena Heise to ask her about credibility in neuroscience, how she became involved in promoting it, and how other players in research can help advance the credibility cause.

Kicking off "The Evolution of Proteomics" series is a pioneer of proteomics, Professor Ruedi Aebersold. Aebersold's research in quantitative proteomics has helped shape our understanding of how proteins function, interact and are localized in both normal and diseased states.

The latest advancements in computer vision technology could be set to change the way we approach diagnostics. This rapidly evolving field uses artificial intelligence to help physicians better perform their analytical duties and improve their accuracy rate in diagnosis through medical imaging.

The human brain sequesters many mysteries. How does cognitive development take place? How does it help us learn? What causes brain diseases? An exciting venture involving researchers from Argonne National Laboratory, the University of Chicago, Harvard University, and Princeton University is preparing to unleash a $500-million supercomputer, dubbed Aurora, in the pursuit of these answers.